MINRETUMOMAB
UNII 235435CH6L

Substance Identification & Data

This profile provides standardized clinical and technical data for Minretumomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 235435CH6L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 195189-17-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

235435CH6L

CAS Registry Number

195189-17-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MINRETUMOMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C2567

National Cancer Institute reference terminology for clinical and research data.

INN ID

7821

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JJ-90

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Minretumomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MINRETUMOMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR-ASSOCIATED GLYCOPROTEIN 72) (MOUSE MONOCLONAL MAB CC49 .GAMMA.1-CHAIN) DISULFIDE WITH MOUSE MONOCLONAL MAB CC49 .KAPPA.-CHAIN, DIMER

MINRETUMOMAB [INN]

MINRETUMOMAB [USAN]